<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00982969</url>
  </required_header>
  <id_info>
    <org_study_id>QFTinROKmilitary</org_study_id>
    <nct_id>NCT00982969</nct_id>
  </id_info>
  <brief_title>The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis</brief_title>
  <official_title>The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis Among Young Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Armed Forces Capital Hospital, Republic of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Armed Forces Capital Hospital, Republic of Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will evaluate the usefulness of QuantiFERON-TB Gold in-tube (QFT) in the
      diagnosis of active tuberculosis in young adults group, highly clinically suspected
      tuberculosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will enroll prospectively all clinically and radiologically suspected
      tuberculosis patients from 20 to 29 years old who visited the Armed Forces Capital Hospital.
      Investigators will perform QFT and tuberculin skin test. Diagnosis of tuberculosis will be
      made by World Health Organization guideline and the physician will not know the
      QuantiFERON-TB Gold in-tube results before the diagnosis and anti-tuberculosis medication.
      Investigators will evaluate the sensitivity and specificity of QuantiFERON-TB Gold in-tube in
      the diagnosis of active tuberculosis among young adults.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>TB suspected</arm_group_label>
    <description>Soldiers who are clinically suspected with tuberculosis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Soldiers in South Korean Army
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All clinically and radiologically suspected TB patients from 20 to 29 years old who
             visited the Armed Forces Capital Hospital

        Exclusion Criteria:

          -  Soldiers who do not agree with study protocol
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Armed Forces Capital Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-040</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2009</study_first_submitted>
  <study_first_submitted_qc>September 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2009</study_first_posted>
  <last_update_submitted>July 19, 2010</last_update_submitted>
  <last_update_submitted_qc>July 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Sei Won Lee/Division chief of pulmonology</name_title>
    <organization>Armed Forces Capital Hospital</organization>
  </responsible_party>
  <keyword>tuberculosis</keyword>
  <keyword>pneumonia</keyword>
  <keyword>QuantiFERON-TB Gold in-tube</keyword>
  <keyword>Tuberculin skin test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

